Professional Summary
I recently obtained my PhD in Neuroscience and Pharmacology (September 2025, with highest honors) from the University of Paris-Saclay, in collaboration with the CEA. My doctoral research focused on understanding cerebral hypoxia using translational models, including brain and choroid plexus organoids as well as in vitro blood-brain barrier (BBB) systems. I also evaluated the neuroprotective potential of a promising purine-derived drug candidate in preclinical models of Hypoxic-Ischemic Encephalopathy (HIE).
Throughout my research journey, I have gained strong expertise in neuroinflammation, Parkinson’s disease, ALS, and cerebrovascular disorders. I am deeply passionate about advancing translational neuroscience and bridging the gap between human-based models and therapeutic development.
In parallel, I am actively involved in the scientific community as a member of the organizing committees for the GDR Organoids Webinar and the SEISC Symposium on the Brain–Blood Interface.
Always eager to collaborate, I strive to contribute to innovative and impactful advances in neuroscience and pharmacology.
Leave your rating